Compound Uncommon EGFR Mutations in a Patient with Advanced NSCLC and Durable Response to Sequential EGFR Targeted Therapies.

导出原文传递

翻译打印收藏纠错

第一作者： Mary Linton B,Peters

第一单位： Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts.

作者： Mary Linton B,Peters ^[1] ; Daniel B,Costa ^[1] ; Deepa,Rangachari ^[2]

作者单位： Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. ^[1] Division of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts. Electronic address: drangach@bidmc.harvard.edu. ^[2]

主题词癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);人类(Humans);肺肿瘤(Lung Neoplasms);突变(Mutation)

DOI 10.1016/j.jtho.2016.12.018

PMID 28343545

发布时间 2018-12-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交